PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy

Brain

Volumn 131, Issue 10, 2008, Pages 2751-2764

  Didelot, Adrien ^a,b,c,d   Ryvlin, Philippe ^a,b,c,d,e   Lothe, Amélie ^c,d   Merlet, Isabelle ^c,f   Hammers, Alexander ^g   Mauguière, François ^a,b,c,d  

^a HÔPITAL NEUROLOGIQUE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d Institut Federatif des Neurosciences de Lyon   (France)

^e CERMEP IMAGERIE DU VIVANT   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Brain 5 HT1A receptors; Presurgical evaluation; Serotonin; Temporal lobe epilepsy; 18F MPPF PET

Indexed keywords

MPPF F 18; SEROTONIN 1A RECEPTOR; TRACER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY;

EID: 54949110628     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn220     Document Type: Article

References (41)

1. Andrade R, Nicoll RA. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol 1987; 394: 99-124.
2. Ashburner J, Friston K. Multimodal image coregistration and partitioning - a unified framework. Neuroimage 1997; 6: 209-17.
3. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999; 38: 1083-152.
4. Beck SG, Choi KC. 5-Hydroxytryptamine hyperpolarizes CA3 hippocampal pyramidal cells through an increase in potassium conductance. Neurosci Lett 1991; 133: 93-6.
5. Bouvard S, Costes N, Bonnefoi F, Lavenne F, Mauguière F, Delforge J, et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. Brain 2005; 128: 1330-43.
6. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 1997; 38: 1614-23.
7. Cidis Meltzer C, Drevets WC, Price JC, Mathis CA, Lopresti B, Greer PJ, et al. Gender-specific aging effects on the serotonin 1A receptor. Brain Res 2001; 895: 9-17.
8. Costes N, Merlet I, Ostrowsky K, Faillenot I, Lavenne F, Zimmer L, et al. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med 2005; 46: 1980-9.
9. Costes N, Merlet I, Zimmer L, Lavenne F, Cinotti L, Delforge J, et al. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. J Cereb Blood Flow Metab 2002; 22: 753-65.
10. Engel J Jr. Intracerebral recordings: organization of the human epileptogenic region. J Clin Neurophysiol 1993; 10: 90-8.
11. French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 1993; 34: 774-80.
12. Friston KJ. Commentary and opinion: II. Statistical parametric mapping: ontology and current issues. J Cereb Blood Flow Metab 1995; 15: 361-70.
13. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42: 1S-93S.
14. Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partialvolume correction. J Nucl Med 2005; 46: 1128-35.
15. Gousias IS, Rueckert D, Heckemann RA, Dyet LE, Boardman JP, Edwards AD, et al. Automatic segmentation of brain MRIs of 2-yearolds into 83 regions of interest. Neuroimage 2008; 40: 672-84.
16. Guenot M, Isnard J, Ryvlin P, Fischer C, Mauguiere F, Sindou M. SEEG-guided RF. thermocoagulation of epileptic foci: feasibility, safety, and preliminary results. Epilepsia 2004; 45: 1368-74.
17. Guenot M, Isnard J, Ryvlin P, Fischer C, Ostrowsky K, Mauguiere F, et al. Neurophysiological monitoring for epilepsy surgery: the Talairach SEEG method. Indications, results, complications and therapeutic applications in a series of 100 consecutive cases. Stereotact Funct Neurosurg 2001; 77: 29-32.
18. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, et al. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 1998; 8: 426-40.
19. Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003; 19: 224-47.
20. Hammers A, Asselin MC, Turkheimer FE, Hinz R, Osman S, Hotton G, et al. Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [(11)C]diprenorphine testretest data. Neuroimage 2007; 38: 82-94.
21. Hammers A, Koepp MJ, Labbé C, Brooks DJ, Thom M, Cunningham VJ, et al. Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001; 56: 897-906.
22. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007; 27: 1533-9.
23. Isnard J, Guenot M, Ostrowsky K, Sindou M, Mauguiere F. The role of the insular cortex in temporal lobe epilepsy. Ann Neurol 2000; 48: 614-23.
24. Isnard J, Guenot M, Sindou M, Mauguiere F. Clinical manifestations of insular lobe seizures: a stereo-electroencephalographic study. Epilepsia 2004; 45: 1079-90.
25. Kang KW, Lee DS, Cho JH, Lee JS, Yeo JS, Lee SK, et al. Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas. Neuroimage 2001; 14: 1-6.
26. Kung HF, Stevenson DA, Zhuang ZP, Kung MP, Frederick D, Hurt SD. New 5-HT1A receptor antagonist: [3H]p-MPPF. Synapse 1996; 23: 344-6.
27. Le Bars D, Lemaire C, Ginovart N, Plenevaux A, Aerts J, Brihaye C, et al. High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol 1998; 25: 343-50.
28. Lopez-Meraz M-L, Gonzalez-Trujano M-E, Neri-Bazan L, Hong E, Rocha LL. 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology 2005; 49: 367-75.
29. 18F MPPF PET study. Brain 2008 [Epub 2 September, 2008].
30. Mauguière F. PET scan in the interictal period: its contribution to evaluation of the functional deficit and epileptogenic zones. In: Rosenow F and Lüders H, editors. Presurgical assessment of the epilepsies with clinical neurophysiology and functional imaging. In: Daube J and Mauguière F series editors. Handbook of Clinical Neurophysiology. Vol. 3. Amsterdam: Elsevier; 2004. p. 219-44.
31. Merlet I, Ostrowsky K, Costes N, Ryvlin P, Isnard J, Faillenot I, et al. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 2004a; 127: 900-13.
32. Merlet I, Ryvlin P, Costes N, Dufournel D, Isnard J, Faillenot I, et al. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage 2004b; 22: 886-96.
33. Okuhara DY, Beck SG. 5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. J Neurophysiol 1994; 71: 2161-7.
34. Rosenow F, Luders H. Presurgical evaluation of epilepsy. Brain 2001; 124: 1683-700.
35. Ryvlin P, Philippon B, Cinotti L, Froment JC, Le Bars D, Mauguiere F. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18FDG-PET and 99mTc-HMPAO-SPECT. Ann Neurol 1992; 31: 650-6.
36. Savic I, Lindstrom P, Gulyas B, Halldin C, Andree B, Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004; 62: 1343-51.
37. Silfvenius H, Gloor P, Rasmussen T. Evaluation of insular ablation in surgical treatment of temporal lobe epilepsy. Epilepsia 1964; 5: 307-20.
38. Sindou M, Guenot M, Isnard J, Ryvlin P, Fischer C, Mauguiere F. Temporo-mesial epilepsy surgery: outcome and complications in 100 consecutive adult patients. Acta Neurochir (Wien) 2006; 148: 39-45.
39. Theodore WH, Hasler G, Giovacchini G, Kelley K, Reeves-Tyer P, Herscovitch P, et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 2007; 48: 1526-30.
40. Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 2003; 60: 749-56.
41. Williamson PD, French JA, Thadani VM, Kim JH, Novelly RA, Spencer SS, et al. Characteristics of medial temporal lobe epilepsy: II. Interictal and ictal scalp electroencephalography, neuropsychological testing, neuroimaging, surgical results, and pathology. Ann Neurol 1993; 34: 781-7.